Literature DB >> 29623246

Obesity and Breast Cancer: A Complex Relationship.

Victoria M Gershuni1, Rexford S Ahima2, Julia Tchou3.   

Abstract

As prevalence of obesity continues to rise in the United States, we are beginning to elucidate the complex role of obesity-associated chronic inflammation, endocrine dysfunction, and hormone production as a driver for increased breast cancer risk. Epidemiological data suggest that obesity (BMI > 30) is associated with increased breast cancer incidence, worse prognosis, and higher mortality rates. Mechanistically, obesity and excess fat mass represent a state of chronic inflammation, insulin resistance, adipokine imbalance, and increased estrogen signaling. This pro-tumorigenic environment stimulates cancer development through abnormal growth, proliferation, and survival of mammary tissue. Importantly, obesity is a modifiable risk factor; alterations in cell proliferation, apoptosis, circulating estrogen, and insulin sensitivity are observed in response to weight loss attainable through behavior modification including dietary and exercise changes.

Entities:  

Keywords:  Adipocyte; Adipokines; Adiponectin; Aromatase; BMI; Breast cancer; Estrogen receptor; Hyperglycemia; Hyperinsulinemia; Inflammation; Insulin resistance; Leptin; Metabolic syndrome; Obesity; Overweight

Year:  2016        PMID: 29623246      PMCID: PMC5882072          DOI: 10.1007/s40137-016-0134-5

Source DB:  PubMed          Journal:  Curr Surg Rep        ISSN: 2167-4817


  111 in total

Review 1.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

2.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans.

Authors:  Saverio Cinti; Grant Mitchell; Giorgio Barbatelli; Incoronata Murano; Enzo Ceresi; Emanuela Faloia; Shupei Wang; Melanie Fortier; Andrew S Greenberg; Martin S Obin
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

Review 3.  Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.

Authors:  Heather K Neilson; Christine M Friedenreich; Nigel T Brockton; Robert C Millikan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

Review 4.  Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.

Authors:  Andreas Schäffler; Jürgen Schölmerich; Christa Buechler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-04

5.  Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms.

Authors:  Bin Su; Cynthie Wong; Yanyan Hong; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-26       Impact factor: 4.292

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line.

Authors:  Stefania Catalano; Stefania Marsico; Cinzia Giordano; Loredana Mauro; Pietro Rizza; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

8.  Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss.

Authors:  P Dandona; R Weinstock; K Thusu; E Abdel-Rahman; A Aljada; T Wadden
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

9.  Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.

Authors:  Sarah M Dunlap; Lucia J Chiao; Leticia Nogueira; Jerry Usary; Charles M Perou; Lyuba Varticovski; Stephen D Hursting
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-15

Review 10.  Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.

Authors:  Diana Barb; Catherine J Williams; Anke K Neuwirth; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

View more
  4 in total

Review 1.  Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights.

Authors:  Federica Biello; Francesca Platini; Francesca D'Avanzo; Carlo Cattrini; Alessia Mennitto; Silvia Genestroni; Veronica Martini; Paolo Marzullo; Gianluca Aimaretti; Alessandra Gennari
Journal:  Biomolecules       Date:  2021-01-19

2.  Association between clinicopathological features of breast cancer with adipocytokine levels and oxidative stress markers before and after chemotherapy.

Authors:  Joanna Grupińska; Magdalena Budzyń; Jacek J Brzeziński; Bogna Gryszczyńska; Magdalena P Kasprzak; Witold Kycler; Ewa Leporowska; Maria Iskra
Journal:  Biomed Rep       Date:  2021-01-28

3.  Obesity modulates the immune macroenvironment associated with breast cancer development.

Authors:  Aleida Núñez-Ruiz; Flor Sánchez-Brena; Cynthia López-Pacheco; Naray A Acevedo-Domínguez; Gloria Soldevila
Journal:  PLoS One       Date:  2022-04-26       Impact factor: 3.752

4.  Dose-dependent effects of aerobic exercise on clinically relevant biomarkers among healthy women at high genetic risk for breast cancer: A secondary analysis of a randomized controlled study.

Authors:  Christopher J Ehret; Shouhao Zhou; Julia C Tchou; Kathryn H Schmitz; Kathleen M Sturgeon
Journal:  Cancer Rep (Hoboken)       Date:  2021-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.